Thomas E. Friel

FDA investigator · also recorded as Thomas Friel

Appears on 13 documents from 2013 to 2017, mostly at sites in Pennsylvania. Most often cites control of microbiological contamination (21 CFR 211.113).

13
Documents on file
5.3
Observations per 483
2013
First seen
2017
Most recent

What they cite most

From 58 observations

Activity by year

2013: 2, 2014: 3, 2015: 3, 2016: 3, 2017: 2

Where

Pennsylvania 9 · Delaware 1 · Florida 1 · Maryland 1 · New Jersey 1

Is Thomas E. Friel coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Pharmaceutics International, Inc.Oct 27, 2017 · Cockeysville, Maryland
483 Biomed PA Inc. dba Soleo HealthJul 6, 2017 · Sharon Hill, Pennsylvania
483 Alfred I. duPont Hospital for ChildrenJun 29, 2016 · Wilmington, Delaware
483 Enclara Pharmacia Inc.Jun 6, 2016 · Shar on Hill, Pennsylvania
483 Ranier’s Compounding LaboratoryApr 22, 2016 · Jeannette, Pennsylvania
483 McNeil Consumer PharmaceuticalMay 6, 2015 · Fort Washington, Pennsylvania
Amended 483 McNeil Consumer Pharmaceutical ProductsMar 27, 2015 · Lancaster, Pennsylvania

About this profile

What does Thomas E. Friel inspect?

Thomas E. Friel appears on 13 documents on file covering 11 sites, mostly in Pennsylvania.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.167.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Thomas E. Friel is dated Oct 27, 2017.